1. Founded on Sep. 3, 2001, Golden Meditech Holdings Limited is mainly engaged in medical equipment, medical services and strategic investment. It got listed in 2001 in Hong Kong. It purchased CMED in 2003 and CMED was listed in NASDAQ in 2005, the first one listed in US..in the medical industry. It was listed on TDR and began to be exchanged on Jan. 24, 2011. 2. Business class and background: A. the main controller is Chaiman & CEO Gan Yuan. Other exective directors are Jin Lu, Lu Tian Long and Zheng Ting. Independent non-executive directors are mostly seniors in accounting, legal and biological physics who are: Cao Gang, Gao Zong Ze and Gu Qiao. B. Other major shareholders are venture capital, such as: Jayhawk Private Equity Fund II, LP, Martin Currie (Holdings) Limited, JP Morgan Chase & Co.. 3. Operational Highlights: the business of Golden Meditech Holdings Limited can be divided into 3 categories: A. medical equipment business: mainly engaged in R & D and manufacturing & sales of blood-related medical equipment and personal health monitoring devices, such as Autologous Blood Recovery System (ABRS), plasma exchange treatment systems, etc. B. Medical services: including the country's two leading blood disease specialist hospitals. C. Strategic Investment: such as: sales of communication terminal products and so on.
Headquarters
48/F, Bank of China Tower , 1 Garden Road , Central, Hong Kong, China
Pingtung County; TAIWAN;
Contact Details: Purchase the Golden Meditech Holdings Limited report to view the information.
Website: http://www.goldenmeditech.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service